Iris Roth - 13 Feb 2023 Form 3 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role: Chief Operating Officer
Signature: /s/ Andrea Paul, attorney-in-fact for Iris Roth
Issuer symbol: ZNTL
Transactions as of: 13 Feb 2023
Net transactions value: $0
Form type: 3
Filing time: 13 Feb 2023, 06:07:14 UTC
Next filing: 02 Mar 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney